Centrally located at UCLA’s Court of Sciences, Magnify strives to enhance the vibrant culture of entrepreneurship at UCLA and the broader Los Angeles region. Featuring flexible co-working laboratory and office spaces, Magnify was built with one goal in mind: to help startups succeed by vastly accelerating their access to facilities while increasing their capital efficiency and market opportunities.
Featured News
June 17, 2026 | Higher ed funding for California veterans is under threat. How a $12 billion bond could help
June 3, 2026 | Magnify Incubator Startup Meteor Biotech Gains Recognition for Spatial Biology Platform
Magnify Incubator Startup Meteor Biotech Gains Recognition for Spatial Biology Platform By Nicole Wilkins (Image courtesy: Emily Kim) Meteor Biotech, a startup company based in the Magnify Incubator at the California NanoSystems Institute at UCLA, recently earned 2nd...
May 26, 2026 | Black-Owned Sun Care Brand ‘My Block Skin’ Expands Into Scientific Innovation With Patent-Pending Mineral SPF Technology
Black-Owned Sun Care Brand ‘My Block Skin’ Expands Into Scientific Innovation With Patent-Pending Mineral SPF Technology Inclusive SPF company known for transparent gel sunscreens enters into next-gen mineral sun care technology...
October 15, 2025 | Pelage Pharmaceuticals Announces $120 Million Series B Financing to Advance Regenerative Medicine Treatments for Hair Loss
Pelage Pharmaceuticals Announces $120 Million Series B Financing to Advance Regenerative Medicine Treatments for Hair Loss This article was originally published by Yahoo Finance Financing co-led by ARCH Venture Partners and GV (Google...
October 8, 2025 | ImmunoVec Launches from Stealth with up to $40.7 Million ARPA-H EMBODY Award to Advance In Vivo Cell Engineering Platform for Autoimmune Diseases
ImmunoVec Launches from Stealth with up to $40.7 Million ARPA-H EMBODY Award to Advance In Vivo Cell Engineering Platform for Autoimmune Diseases Novel platform uses DNA-loaded polymeric nanoparticles to precisely reprogram cells in...
September 10, 2025 | CNSI Magnify Internship Program Celebrates Third Cohort of Student Innovators
CNSI Magnify Internship Program Celebrates Third Cohort of Student Innovators By Nicole Wilkins his past academic year UCLA undergraduates gained firsthand experience in the fast-paced world of startups through the...
June 13, 2025 | LA’s premier innovation conferences combine for inaugural LABEST Week
LA’s premier innovation conferences combine for inaugural LABEST Week Panelists at LABEST are pictured. The UCLA Technology Development Group united the UCLA MedTech Conference and LA Bioscience Ecosystem Summit for the inaugural LABEST...
March 3, 2025 | Q&A With Nikki Lin
February 27, 2025 | Sorriso Pharmaceuticals Presents Positive SOR102 Phase 1b Ulcerative Colitis Data at ECCO Conference
Sorriso Pharmaceuticals, a biopharmaceutical company developing novel orally dosed antibodies for immune-mediated disease, today announced the presentation of Phase 1b clinical data from of SOR102, its first-in-class oral biologic targeting TNFα and IL-23p19, in...
December 19, 2024 | Sorriso Pharmaceuticals Announces Positive Phase 1b Clinical Trial Results for SOR102 in Ulcerative Colitis
Sorriso Pharmaceuticals, a biopharmaceutical company developing novel orally dosed antibodies for immune-mediated disease, today announced positive results from its Phase 1b clinical trial evaluating SOR102, an oral, dual-acting biologic targeting TNFα and IL-23, in...
Give to Support a Brighter Future through Nanoscience and Nanotechnology
Your generous support of the California NanoSystems Institute at UCLA will drive innovations that address society’s most urgent challenges and give life to promising ideas for a prosperous future together.